The aryl hydrocarbon receptor (AhR) and aryl hydrocarbon receptor nuclear translocator (ARNT) complex is one of the transcription factors of NRF2, and the activity of this complex has been suggested to reduce cancer metastasis through increasing the expression of NRF232–34. Here, AHR is linked to cancer.